Montis Financial’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,549
| Closed | -$207K | – | 145 |
|
|
2025
Q1 | $207K | Hold |
2,549
| – | – | 0.06% | 140 |
|
|
2024
Q4 | $230K | Hold |
2,549
| – | – | 0.07% | 125 |
|
|
2024
Q3 | $252K | Hold |
2,549
| – | – | 0.09% | 97 |
|
|
2024
Q2 | $236K | Hold |
2,549
| – | – | 0.11% | 72 |
|
|
2024
Q1 | $242K | Hold |
2,549
| – | – | 0.11% | 75 |
|
|
2023
Q4 | $228K | Buy |
+2,549
| New | +$228K | 0.14% | 68 |
|
|
2023
Q3 | – | Sell |
-2,699
| Closed | -$225K | – | 75 |
|
|
2023
Q2 | $225K | Hold |
2,699
| – | – | 0.15% | 57 |
|
|
2023
Q1 | $206K | Sell |
2,699
-12
| -0.4% | -$915 | 0.16% | 58 |
|
|
2022
Q4 | $225K | Sell |
2,711
-2,935
| -52% | -$244K | 0.19% | 56 |
|
|
2022
Q3 | $448K | Hold |
5,646
| – | – | 0.43% | 33 |
|
|
2022
Q2 | $419K | Buy |
5,646
+1,494
| +36% | +$111K | 0.39% | 34 |
|
|
2022
Q1 | $373K | Buy |
4,152
+1,615
| +64% | +$145K | 0.29% | 38 |
|
|
2021
Q4 | $284K | Hold |
2,537
| – | – | 0.21% | 58 |
|
|
2021
Q3 | $313K | Sell |
2,537
-433
| -15% | -$53.4K | 0.27% | 39 |
|
|
2021
Q2 | $402K | Buy |
2,970
+1,044
| +54% | +$141K | 0.33% | 41 |
|
|
2021
Q1 | $264K | Hold |
1,926
| – | – | 0.25% | 54 |
|
|
2020
Q4 | $293K | Buy |
+1,926
| New | +$293K | 0.29% | 48 |
|